PSD-95 inhibitor
A technology of -AA2 and -AA3 is applied in the direction of peptide-nucleic acid, medical preparations containing active ingredients, peptide/protein components, etc., which can solve the problems of lack of treatment methods and achieve stable properties and significant protective effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] The preparation of embodiment 1 compound 1
[0032] Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-
[0033] Glu-Ser-Asp-Val-Lys(Pal-γGlu)-NH 2
[0034] The preparation method includes: preparing the peptide resin by solid-phase polypeptide synthesis method, acid hydrolyzing the peptide resin to obtain a crude product, and finally purifying the crude product to obtain a pure product; wherein the step of preparing the peptide resin by the solid-phase polypeptide synthesis method is to pass solid-phase The phase-coupled synthesis method sequentially inserts the corresponding protected amino acids or fragments in the following sequences to prepare peptide resins:
[0035] In the above preparation method, the amount of the Fmoc-protected amino acid or protected amino acid fragment is 1.2-6 times of the total moles of the resin fed; preferably 2.5-3.5 times.
[0036] In the above preparation method, the substitution value of the carrier resin is 0.2-1.0 m...
Embodiment 2
[0072] The preparation of embodiment 2 compound 2
[0073] Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-
[0074] Glu-Ser-Asp-Val-Lys(2-cholesterol butyrate)-NH 2
[0075] The preparation method is the same as in Example 1, and the protected amino acids used are as follows:
[0076]
[0077]
[0078] 7.2 g of pure product was obtained, the purity was 95.8%, and the total yield was 23.2%. The molecular weight is 3100.8 (100% M+H).
Embodiment 3
[0079] The preparation of embodiment 3 compound 3
[0080] Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Lys-Leu-Ser-Ser-Ile-
[0081] Glu-Ser-Asp-Val-Cys(cholesteryl acetate)-NH 2
[0082] 1. Preparation of peptide resin
[0083] Method is the same as embodiment 1, and the protected amino acid that uses is as following table:
[0084]
[0085]
[0086] 2. Preparation of crude product
[0087] Take the above peptide resin, add a cleavage reagent with a volume ratio of TFA: water: EDT = 95: 5: 5 (cleavage reagent 10mL / g resin), stir well, stir and react at room temperature for 3 hours, use a sand core funnel to filter the reaction mixture, collect The filtrate and the resin were washed 3 times with a small amount of TFA, the combined filtrates were concentrated under reduced pressure, anhydrous ether was added to precipitate, and then the precipitate was washed with anhydrous ether 3 times, dried to obtain off-white powder, dissolved in pure DMSO, added Equal molar tri...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com